Buch, Englisch, 436 Seiten, Previously published in hardcover, Format (B × H): 178 mm x 254 mm, Gewicht: 851 g
Reihe: Infectious Disease
Buch, Englisch, 436 Seiten, Previously published in hardcover, Format (B × H): 178 mm x 254 mm, Gewicht: 851 g
Reihe: Infectious Disease
ISBN: 978-1-61737-247-6
Verlag: Humana Press
A comprehensive review of what is known about the role of cytokines and chemokines in a variety of human infectious diseases, including gram-negative and -positive infections, listeriosis, mycobacterial infections, lyme arthritis, pneumonia, fungal infections, HIV, leishmaniasis, and sepsis. The authors demonstrate the different cytokine and chemokine production profiles in response to a wide variety of pathogens and the importance of host genetic factors in determining the type and magnitude of responses to a given microorganism. They also critically evaluate the use of cytokines and anticytokines in the treatment of infectious diseases and show how knowledge of cytokine pleiotropic effects, redundancy, and the complexity of the cytokine network has led to better design and better outcomes in cytokine-based therapies for specific infections.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Biochemie (med.)
Weitere Infos & Material
Introduction: Cytokine Biology Relevant to Infectious Diseases.- I Cytokines in Infectious Diseases.- 1 Leptin: Its Role in Immunomodulation and Susceptibility to Infection.- 2 Cytokine Gene Polymorphism and Host Susceptibility to Infection.- II Cytokines in Gram-Negative Infections.- 3 Proinflammatory and Anti-Inflammatory Cytokines as Mediators of Gram-Negative Sepsis.- 4 Host Response to Pathogenic Bacteria at Mucosal Sites.- 5 Macrophage Migration Inhibitory Factor as a Cytokine of Innate Immunity.- III Cytokines in Gram-Positive Infections.- 6 Cytokine Patterns in Severe Invasive Group A Streptococcal Infections.- 7 Superantigens and Bacterial DNA as Cytokine Inducers in Gram-Positive Sepsis.- 8 Cytokines and Chemokines in Listeriosis.- IV Cytokines in Mycobacterial Infections.- 9 Regulation of Cytokines and Chemokines in Human Mycobacterium tuberculosis Infection.- 10 Cytokines and Chemokines in Protective and Inflammatory Responses to Infection with Nontuberculous Mycobacteria.- 11 Human Interleukin-12—Interferon-? Axis in Protective Immunity to Mycobacteria.- 12 Role of Th1 Cytokines in Host Defenses Against Mycobacterium leprae.- V Cytokines in Other Bacterial Infections.- 13 Possible Role of Molecular Mimicry in Lyme Arthritis.- 14 Cytokine Responses in Patients with Pneumonia.- VI Cytokines in Fungal Infections.- 15 Cytokines and the Host Defense Against Aspergillus fumigatus.- 16 Cytokines of Innate and Adaptive Immunity to Candida albicans.- VII Cytokines in Parasitic Infections.- 17 Th1 and Th2 Cytokines in Leishmaniasis.- 18 Cytokines in the Regulation of Innate and Adaptive Immunity to Toxoplasma gondii.- VIII Cytokines in Viral Infections.- 19 Viroceptors: Virus-Encoded Receptors for Cytokines and Chemokines.- 20 Chemokines and Chemokine Receptors inHIV Infection.- 21 Cytokines in Viral Hepatitis.- IX Cytokines as Therapeutic Agents in Infectious Diseases.- 22 Interferon-? in the Treatment of Infectious Diseases.- 23 Interleukin-2 for the Treatment of HIV Infection.- 24 Clinical Applications of G-CSF and GM-CSF in the Treatment of Infectious Diseases.- X Anticytokine-Based Therapy in Treatment of Infectious Diseases.- 25 Anticytokine Therapies in Patients with Severe Sepsis and Septic Shock.- 26 Intravenous Immunoglobulin Adjunctive Therapy in Patients with Streptococcal Toxic Shock Syndrome and Necrotizing Fasciitis.
